Stay updated with breaking news from Nyxoah sa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A number of research firms have changed their ratings and price targets for Nyxoah (NASDAQ: NYXH): 3/20/2024 – Nyxoah had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock, up previously from $18.00. 3/20/2024 – Nyxoah had its price target raised by analysts at Stifel […] ....
Nyxoah Reports Third Quarter 2023 Financial and Operating ResultsPartners with ResMed Germany to increase OSA awareness and therapy penetration Mont-Saint-Guibert, Belgium – November 8, 2023 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the third quarter ....
Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference Mont-Saint-Guibert, Belgium – September 12, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Cantor Fitzgerald Global Healthcare Conference, which takes place September 2 ....
Nyxoah SA (NYXH) delivered earnings and revenue surprises of -8.89% and 15.64%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? ....